Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2026-01-22 @ 6:17 PM
Study NCT ID:
NCT01765361
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2012-12-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EP-OCR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None